Kurum Yazarı "Keklikkıran, Çağlayan" TF, Dahili Tıp Bilimleri Bölümü Koleksiyonu İçin Listeleme
-
Can frequent toothbrushing reduce the risk of cirrhosis among patients with non-alcoholic fatty liver disease? Hints from a registry-based study
Keklikkıran, Çağlayan; Stepanova, Maria; Younossi, Zobair; Yılmaz, Yusuf (Karger, 2023)Introduction: While poor oral hygiene has been previously associated with an increased risk of non-alcoholic fatty liver disease (NAFLD), its association with hepatic fibrosis remains unclear. Here, we sought to analyze ... -
Diagnostic accuracy of AGILE3+ score for advanced fibrosis in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis
Dalbeni, Andrea; Lombardi, Rosa; Henrique, Matteus; Zoncapè, Mirko; Pennisi, Grazia; Petta, Salvatore; Tateishi, Ryosuke; Keklikkıran, Çağlayan; Colecchia, Antonio; Sacerdoti, David; Mantovani, Alessandro; Ravaioli, Federico (Lippincott Williams & Wilkins, 2023)Background and aims: A simple non-invasive score, the Agile3+ score, combining liver stiffness measurement (LSM), aspartate aminotransferase/alanine aminotransferase ratio, platelet count, diabetes status, sex, and age, ... -
Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease
Younossi, Zobair M.; Alqahtani, Saleh A.; Alswat, Khalid; Yılmaz, Yusuf; Keklikkıran, Çağlayan; Funuyet-Salas, Jesús; Romero-Gómez, Manuel; Fan, Jian-Gao; Zheng, Ming-Hua; El-Kassas, Mohamed; Castera, Laurent; Liu, Chun-Jen; Wai-Sun Wong, Vincent; Zelber-Sagi, Shira; Allen, Alina M.; Lam, Brian; Treeprasertsuk, Sombat; Hameed, Saeed; Takahashi, Hirokazu; Kawaguchi, Takumi; Schattenberg, Jörn M.; Duseja, Ajay; Newsome, Phil N.; Francque, Sven; Spearman, C. Wendy; Castellanos Fernández, Marlen I.; Burra, Patrizia; Roberts, Stuart K.; Chan, Wah-Kheong; Arrese, Marco; Silva, Marcelo; Rinella, Mary; Singal, Ashwani K.; Gordon, Stuart; Fuchs, Michael; Alkhouri, Naim; Cusi, Kenneth; Loomba, Rohit; Ranagan, Jane; Eskridge, Wayne; Kautz, Achim; Ong, Janus P.; Kugelmas, Marcelo; Eguchi, Yuichiro; Diago, Moises; Yu, Ming-Lung; Gerber, Lynn; Fornaresio, Lisa; Nader, Fatema; Henry, Linda; Racila, Andrei; Golabi, Pegah; Stepanova, Maria; Carrieri, Patrizia; Lazarus, Jeffrey V. (Elsevier, 2023)Background & Aims: Patients with fatty liver disease may experience stigma from the disease or comorbidities. In this crosssectional study, we aimed to understand stigma among patients with nonalcoholic fatty liver disease ... -
The impact of stigma on quality of life and liver disease burden among patients with nonalcoholic fatty liver disease
Younossi, Zobair M.; AlQahtani, Saleh A.; Funuyet-Salas, Jesús; Romero-Gómez, Manuel; Yılmaz, Yusuf; Keklikkıran, Çağlayan; Alswat, Khalid; Yu, Ming-Lung; Liu, Chun-Jen; Fan, Jian-Gao; Zheng, Ming-Hua; Burra, Patrizia; Francque, Sven M.; Castera, Laurent; Schattenberg, Jörn M.; Newsome, Philip N.; Allen, Alina M.; El-Kassas, Mohamed; Treeprasertsuk, Sombat; Hameed, Saeed; Wai-Sun Wong, Vincent; Zelber-Sagi, Shira; Takahashi, Hirokazu; Kawaguchi, Takumi; Castellanos Fernández, Marlen I.; Duseja, Ajay; Arrese, Marco; Rinella, Mary; Singal, Ashwani K.; Gordon, Stuart C.; Fuchs, Michael; Eskridge, Wayne; Alkhouri, Naim; Cusi, Kenneth; Loomba, Rohit; Ranagan, Jane; Kautz, Achim; Ong, Janus P.; Kugelmas, Marcelo; Eguchi, Yuichiro; Diago, Moises; Gerber, Lynn; Lam, Brian; Fornaresio, Lisa; Nader, Fatema; Spearman, C. Wendy; Roberts, Stuart K.; Chan, Wah-Kheong; Silva, Marcelo; Racila, Andrei; Golabi, Pegah; Ananchuensook, Prooksa; Henry, Linda; Stepanova, Maria; Carrieri, Patrizia; Lazarus, Jeffrey V. (Elsevier, 2024)Background & Aims: Patients with nonalcoholic fatty liver disease (NAFLD)/metabolic dysfunction-associated steatotic liver disease (MASLD) face a multifaceted disease burden which includes impaired health-related quality ... -
Impairment of patient-reported outcomes among patients with non-alcoholic fatty liver disease: a registry-based study
Yılmaz, Yusuf; Toraman, Ahmet Eren; Alp, Ceyda; Doğan, Zehra; Keklikkıran, Çağlayan; Stepanova, Maria; Younossi, Zobair (Wiley, 2022)Background Patients with non-alcoholic fatty liver disease (NAFLD) and more advanced fibrosis tend to have more impairment in their health-related quality of life and other patient-reported outcomes (PROs). Aim To assess ... -
Optimal testing strategies for incidental anti-mitochondrial M2 antibody-positive patients
Ergenç, İlkay; Gözaydinoğlu, Büşra; Keklikkıran, Çağlayan; Yılmaz, Yusuf (Kare Publishing, 2024)We carefully considered the letter entitled “Optimal testing strategies for incidental anti-mitochondrial M2 antibody-positive patients.” We sincerely appreciate the authors’ insights and the thoughtful review of our ... -
Prevalence of metabolic dysfunction-associated steatotic liver disease and steatohepatitis in Türkiye: A forensic autopsy study
Ergenç, İlkay; Kara, Erdoğan; Yılmaz, Muhammed Emre; Demirtaş, Coşkun Özer; Keklikkıran, Çağlayan; Daş, Taner; Büyük, Yalçın; Çelikel, Çiğdem; Aslıyüksek, Hızır; Yılmaz, Yusuf (Elsevier, 2024)Background and aims: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing global epidemic in T & uuml;rkiye and worldwide. The aim of this study was to evaluate the prevalence and predictors of ... -
The risk of development of primary biliary cholangitis among incidental antimitochondrial M2 antibody-positive patients
Ergenç, İlkay; Gözaydınoğlu, Büşra; Keklikkıran, Çağlayan; Yılmaz, Yusuf (Kare Publishing, 2023)Background and Aim: This study investigated the risk of the development of primary biliary cholangitis (PBC) in individuals who were incidentally identified as having positive antimitochondrial antibodies (AMA)-M2.Materials ...